Is there a regional solution to vaccine inequity?
Regionally-based vaccine manufacturing networks can provide the scale and agility needed to combat vaccine inequity that germinated out of the pandemic.
BSc and MD, McGill University. Formerly: Professor of Medicine, Duke University and Chancellor for Health Affairs, President and Chief Executive Officer, Duke University Health System; Professor of Medicine, Stanford University; Professor of Theory and Practice of Medicine, Harvard University; Founder, Corgentech; Founder, Clerigen; former Chairman, CV Therapeutics. Currently: President, US National Academy of Medicine. Author of academic papers, books and patents. Recipient of numerous honours and awards.
Regionally-based vaccine manufacturing networks can provide the scale and agility needed to combat vaccine inequity that germinated out of the pandemic.
Nowadays, it is no longer a fantasy that we can live longer. Life expectancy has nearly doubled in the past 100 years, but ageing is still often viewed as a societal burden.